SCLX Scilex Holding Company
3.960USD+3.66%Mkt Cap: 27.86M $P/E: —Today
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical syst…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap27.86M USD
Enterprise Value131.80M USD
Revenue (TTM)31.61M USD
Gross Profit19.65M USD
Net Income (TTM)-358.73M USD
Revenue/Share3.64 USD
Last Price3.960 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees34
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)5.56
PEG—
EV/EBITDA-0.47
EV/Revenue4.17
P/S0.90
P/B-0.09
EPS (TTM)-49.70
EPS (Forward)0.73
52W Range
2.6157% of range21.34
52W High21.34 USD
52W Low2.615 USD
Profitability
Gross Margin64.97%
Oper. Margin-385.02%
EBITDA Margin0.00%
Profit Margin-1185.78%
ROE172.65%
ROA-98.29%
Growth
Revenue Growth-22.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.82M USD
CapEx (TTM)733.00K USD
FCF Margin-27.98%
FCF Yield-31.74%
Net Debt105.40M USD
Net Debt/EBITDA-0.38
Balance Sheet
Debt/Equity-0.60
Current Ratio0.07
Quick Ratio0.05
Book Value/Sh-43.83 USD
Cash/Share0.08 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1606:1000
Split DateJun 16, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.7.03M
Float5.69M
Insiders11.67%
Institutions8.51%
Short Interest
Short Ratio4.3d
Short % Float3.19%
Short % Out.2.51%
Shares Short176.71K
Short (prev mo.)152.59K
Technical
SMA 505.721 (-30.8%)
SMA 2005.881 (-32.7%)
Beta1.72
S&P 52W Chg14.58%
Avg Vol (30d)38.71K
Avg Vol (10d)34.48K
Technical Indicators
RSI (14)26.4
MACD-0.5245
MACD Signal-0.4729
MACD Hist.-0.0516
BB Upper5.789 USD
BB Middle4.814 USD
BB Lower3.839 USD
BB Width40.52%
ATR (14)0.3860 USD
Vol Ratio (20d)1.74x